Panacos Financial Statements
Panacos Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Panacos Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.2 | 0.3 | 1.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (39.0) | (41.7) | (60.0) |
| Total Net Income ($ mil.) | (37.5) | (38.1) | (59.1) |
| Diluted EPS (Net Income) | (0.70) | (0.75) | (1.72) |
Panacos Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (9.2) | (8.2) | (9.3) |
| Total Net Income ($ mil.) | (9.7) | (8.5) | (9.4) |
| Diluted EPS (Net Income) | (0.18) | (0.16) | (0.17) |
Panacos Stock Quote & Chart
10/06/08 15:00:04 EST •
NASDAQ •
0.24
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Panacos Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 321.84 | 3.75 | 1.56 |
| Price/Earnings Ratio | -- | 16.34 | 15.82 |
| Price/Book Ratio | 2.68 | 2.92 | 1.52 |
| Price/Cash Flow Ratio | -- | 13.17 | 9.88 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Panacos Financial Ratios
Panacos Competitive Intelligence
| Abbott Labs | Bristol-Myers Squibb | Gilead Sciences | |
|---|---|---|---|
| Annual Sales ($ mil.) | 25,914.2 | 19,348.0 | 4,230.0 |
| Employees | 68,000 | 42,000 | 2,979 |
| Market Cap ($ mil.) | 90,488.8 | 43,191.1 | 52,303.3 |
Competitive Landscape
